Imagine needing surgery to remove a tumor from your heart. The old way meant a large cut down the middle of your chest, breaking bones to reach your heart. It is a long, painful recovery.
But what if surgeons could remove that same tumor through tiny cuts, without ever opening your chest fully?
That is the promise of a new surgical technique. It uses a camera and thin instruments inserted through small holes between the ribs. This study tests if this method works for tumors deep inside the heart’s lower chambers, called ventricles.
Heart tumors are rare, but when they happen, they are serious. They can block blood flow, cause heart failure, or break off and travel to the brain. The only real treatment is surgery to remove them.
Most heart tumors grow in the upper chambers (atria). Surgeons have a good keyhole method for those. But tumors in the lower chambers (ventricles) are much harder to reach.
They are deep inside the heart. The space is tight. And there are important valves and muscles nearby. Because of this, surgeons have mostly relied on open-heart surgery for ventricular tumors. That means a big scar, a longer hospital stay, and a tough recovery.
The Old Way vs. The New Way
For decades, the standard was open-heart surgery. The surgeon would split the breastbone to get full access to the heart. It works, but it is a major trauma to the body.
The new way is called a fully thoracoscopic approach. Think of it like using a tiny camera and long tools through a keyhole. The surgeon does not break the breastbone. They work between the ribs.
But here’s the twist: doing this for ventricular tumors is not common. It is technically very difficult. This study looks at whether it can be done safely and effectively.
Think of the heart as a house with four rooms. The ventricles are the two lower rooms. They pump blood to the lungs and the body.
To reach a tumor in a lower room without opening the whole house, surgeons use a special map. They insert a thin tube with a camera (a thoracoscope) through a small cut. This gives them a live video feed inside the chest.
They also insert long, thin instruments through other small cuts. It’s like using long chopsticks through a tiny window. The surgeon watches a monitor and carefully cuts out the tumor.
This study used a specific method: a right-sided, three-port approach. This means all the tools go in from the right side of the chest, using three small holes. This gives the best angle to reach the ventricles without disturbing the breastbone.
Researchers in China reviewed eight patients who had this surgery between August 2022 and July 2025. All patients had tumors in the lower heart chambers. The surgeons used the three-port thoracoscopic method to remove them. They tracked how the patients did during surgery and in the months after.
The results were encouraging. All eight tumors were completely removed. One patient also needed a valve repair, which the surgeons did at the same time.
There were no major problems after surgery. No one died. No one had a stroke or blood clots. This is crucial because heart surgery carries these risks.
The recovery was fast. Patients spent about one day in the intensive care unit. They were on a breathing machine for less than a day. And they went home in about five days. For open-heart surgery, hospital stays are often longer.
Most importantly, at follow-up checks (average of 21 months), no tumors had grown back. No one needed another surgery. The heart valves worked well.
But there’s a catch.
This was a small study of only eight patients. While the results are promising, they are not enough to change medical practice overnight.
This technique is not brand new, but applying it to ventricular tumors is a significant step. It shows that with skill and the right tools, surgeons can avoid the trauma of a large chest incision. This study adds to the evidence that minimally invasive heart surgery is expanding beyond simple procedures. It suggests that for select patients, this could become a standard option.
If you or a loved one has a heart tumor, this is hopeful news. However, this surgery is not yet widely available. It requires a highly skilled surgical team with special training.
This does not mean this treatment is available yet.
Talk to your cardiologist or heart surgeon about all options. Ask if minimally invasive surgery is right for your specific case. Not every tumor or patient is a candidate for this approach.
The study has clear limits. It was a small, retrospective look at only eight patients. There was no comparison group getting open-heart surgery. The follow-up time (about two years) is good but not long enough to see very late effects. More research with more patients is needed.
What happens next? The surgeons will likely continue to refine the technique and collect more data. They may compare outcomes directly with traditional open-heart surgery in a larger trial. If those results are also positive, this method could become a more common choice. For now, it remains a promising alternative in the hands of expert surgeons.